Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.27Price to Sales
VS
Market
Sector
Industry
History
$ 9.17Close
$ 8.1 - $ 25.15 52-Week Range
Ticker Information
Ticker
ANIKCompany Name
ANIKA THERAPEUTICS INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQANIKA THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ANIK - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 116.79M | 1.27 | $ 91.85M |
| 3/31/2025 | $ 166.93M | 1.58 | $ 105.55M |
| 12/31/2024 | $ 228.38M | 1.9 | $ 119.91M |
| 9/30/2024 | $ 250M | 1.52 | $ 164.17M |
| 6/30/2024 | $ 379.98M | 2.28 | $ 166.88M |
| 3/31/2024 | $ 422.17M | 2.49 | $ 169.26M |
| 12/31/2023 | $ 377.78M | 2.27 | $ 166.66M |
| 9/30/2023 | $ 309.22M | 1.89 | $ 163.31M |
| 6/30/2023 | $ 307.98M | 1.9 | $ 162.11M |
| 3/31/2023 | $ 373.21M | 2.37 | $ 157.47M |
Key Performance Insights, Last 5 Years
- ANIKA THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 3.78.
- Over the past 5 years, ANIKA THERAPEUTICS INC's average P/S has been 2.63.
- The median P/S for ANIKA THERAPEUTICS INC during this period was 2.32
- ANIKA THERAPEUTICS INC reached its highest P/S over the past 5 years at 4.67.
- The lowest P/S recorded by ANIKA THERAPEUTICS INC in the same timeframe 1.27
ANIKA THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for ANIKA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 481.87M ] / Revenues [ $ 127.54M ]
(=) P/S [ 3.78 ] ANIK - Price to Sales, Last 5 years
1.27
Minimum
Jun 30, 2025
4.67
Maximum
Mar 31, 2021
2.63
Average
2.32
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |